Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Empirical Research
  • Population Surveillance
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Prostate cancer overdiagnosis has a strong relationship to age and PSA level. Restricting screening in men over 60 to those with PSA above median (>1 ng/ml) and screening men over 70 only in selected circumstances would importantly reduce overdiagnosis and change the ratio of benefits to harms of PSA-screening.

publication date

  • February 11, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3922189

Digital Object Identifier (DOI)

  • 10.1186/1741-7015-12-26

PubMed ID

  • 24512643

Additional Document Info

start page

  • 26

volume

  • 12

number

  • 1